Skip to content
TrialScanner

NCT04904120

Targeted Imaging of Melanoma for Alpha-Particle Radiotherapy

Phase 1CompletedCATXLead

Registry record

Lead sponsor
Perspective Therapeutics
Conditions
Melanoma (Skin); Melanoma Stage IV; Melanoma, Uveal; Melanoma, Mucosal
Primary completion
Sep 20, 2022Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT04904120 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT04904120: Targeted Imaging of Melanoma... | TrialScanner